Hypogonadism Completed Phase 3 Trials for Sodium chloride (DB09153)

IndicationStatusPhase
DBCOND0009256 (Hypogonadism)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02672592Effects of Interleukin-1 Beta on Low Testosterone Levels in Men With Obesity and Metabolic SyndromeTreatment